baber/WOPTO huggingface dataset:
Patent IL-84874-A0 (IL)
Title: Condensed diazepinones,their preparation and pharmaceutical compositions containing them
IPC: C07D471/04
Filed: 1987-12-18
Abstract: There are described new condensed diazepinones of general formula <IMAGE>  (I)  wherein    &cir& B  represents one of the divalent groups   <IMAGE> +TR   <IMAGE>  and D represents the groups   <IMAGE> <IMAGE> +TR   <IMAGE>   and X1, X2 represents a =CH- group or, if &cir& B  assumes the meaning of the divalent group S, U or W, they may also represent an N atom, A1 and A2 in general represent lower alkylene groups, Z represents a C-C bond or the groups, -O-, -S-, -CH2-, or -(CH2)2-; R represents hydrogen or methyl, R1 and R2 generally represent alkyl groups which, together with the nitrogen atom between them, may also form a saturated monocylic, heterocyclic group, R3 represents alkyl, chlorine or hydrogen, R4 represents hydrogen or methyl, R5 and R6 represent hydrogen, halogen or alkyl, R7 represents hydrogen, chlorine or methyl, R8 represents hydrogen or lower alkyl, R9 represents hydrogen, halogen, lower alkyl and R10 represents hydrogen or methyl and R12 represents branched or unbranched alkyl. The compounds of general formula I and the acid addition salts thereof may be resolved into their isomers. The compounds of formula I and their salts may be used as vagal pacemakers for the treatment of bradycardia and bradyarrhythmia.
Patent IL-97403-A0 (IL)
Title: 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones,oxazolidinones,and imidazolidinones and pharmaceutical compositions containing them
IPC: A61K31/425
Filed: 1991-03-04
Abstract: The novel 3,5-ditertiarybutyl-4-hydroxy-phenylmethylene derivative of 2-substituted thiasolidinones, oxazolidinones, and imidazolidinones of formula I <CHEM> as antiinflammatory agents having inhibiting activity for 5-lipoxygenase, cyclooxygenase, or both.
Patent AU-PN020294-A0 (AU)
Title: Compressed frozen vegetable
IPC: A23B7/02
Filed: 1994-12-21
Abstract: The present invention is directed to a process of preparing and/or preserving a partially dehydrated vegetable which is capable of being preserved at or about freezer temperatures, and the product produced thereby.
Patent FI-20021922-A0 (FI)
Inventor: ILM MYOEH
IPC: D21F1/36
Filed: 2002-10-29
Abstract: A fabric guiding equipment for a paper machine having rolls, has vertical bracket and nip guard that form an integrated sheet-metal construction. A fabric guiding equipment for a paper machine having fabric (10) having rolls, comprises: (a) a stand (19) attached to the paper machine frame; (b) a nip guard (26) in the stand at the gaps formed by the roll and fabric; (c) a transfer base (20) movably adapted to the stand; (d) transfer equipment (22) for moving the transfer base in relation to the stand; (e) edge detector(s) (23) for the roll, arranged on the opposite side of the fabric, for determining the fabric position in the axial direction of the roll; and (f) a vertical bracket (25) arranged to the stand for the edge detector. The roll end supported by the equipment is set according to the edge detector by means of the transfer equipment for keeping a desired fabric position at the rolls. The vertical bracket and the nip guard form an integrated sheet-metal construction.
Patent FI-20022157-A0 (FI)
IPC: E04C2/292
Filed: 2002-12-05
Abstract: The invention relates to wall or ceiling panels of buildings, comprising a metallic outer surface plate (3a) and a metallic inner surface plate (3b), and heat insulation (6) provided therebetween. The groove (7) of the tongue and groove joint comprises folds (4a, 4b) extending inwards from the surface plates at the panel edge, as outwardly extensions thereof first bends (9a, 9b) and further inwardly first inner flanges (11a, 11b). The tongue (8) comprises bead strips (5a, 5b) extending outwards from the surface plates at the panel edge, as extensions thereof in the inward direction second bends (10a, 10b) and further in the outward direction second inner flanges (12a, 12b). <IMAGE>
Patent IL-106059-A0 (IL)
Title: Hydroxamic acid derivatives,their manufacture and pharmaceutical compositions containing them
IPC: C07C333/24
Filed: 1993-06-18
Abstract: The invention provides hydroxamic acid derivatives of the formula   <CHEM> wherein R<1> represents 1-7C alkyl; R<2> represents hydrogen, 1-6C alkyl or a group of the formula -(CH2)n-aryl or -(CH2)n-Het in which n stands for 1-4 and Het represents a 5- or 6-membered N-heterocyclic ring which (a) is attached via the N atom, (b) optionally contains N, O and/or S as additional hetero atom(s) in a position or positions other than adjacent to the linking N atom, (c) is substituted by oxo on one or both C atoms adjacent to the linking N atom and (d) is optionally benz-fused or optionally substituted on one or more other carbon atoms by 1-6C alkyl or oxo and/or on any additional N atom(s) by 1-6C alkyl; R<3> represents the characterizing group of a natural or non-natural  alpha -amino acid in which any functional group present may be protected, with the proviso that R<3> does not represent hydrogen; R<4> represents carboxyl, (1-6C alkoxy)-carbonyl, carbamoyl or (1-6C alkyl)carbamoyl; R<5> represents the characterizing group of a naturally occurring  alpha -amino acid in which any functional group present may be protected; and R<6> represents hydrogen; or R<4>, R<5> and R<6> each individually represent hydrogen or 1-6C alkyl, and their pharmaceutically acceptable salts, which are matrix metalloproteinase inhibitors useful for the control or prevention of degenerative joint diseases such as rheumatoid arthritis and osteoarthritis or for the treatment of invasive tumours, atherosclerosis or multiple sclerosis. They can be manufactured according to generally known methods by deprotecting a corresponding novel benzyloxyamino compound or hydroxamidating a corresponding novel amino acid or activated derivative thereof.
Patent IL-137830-A0 (IL)
Title: Monolateral orthopedic device with external fixing
IPC: A61B17/56
Filed: 1999-12-16
Abstract: The invention applies to the field of medicine, particularly to bone surgery. The invention relates to a monolateral orthopedic external fixation device for immobilizing a fractured bone having a rigid support, at least two pins screwed into the bone and joined to the rigid support by a connecting mechanism comprising a pin-holding device composed of two identical parts forming a clamp whose two opposing faces have depressions. These depressions are able to receive and hold pins with diameters from 3 to 6 mm.
Patent IL-140095-A0 (IL)
Title: Method and composition for the treatment of epidermal irritations and infections
IPC: A61K8/36
Filed: 1999-06-09
Abstract: An improved stannous fluoride composition is disclosed. The composition comprises stannous fluoride and at least one zinc containing compound. The zinc containing compounds stabilized and prevent hydrolysis of the stannous ions resulting in a more effective stannous fluoride composition for use in the treatment of epidermal irritations and infections.
Patent IL-141117-A0 (IL)
Title: Means for retaining transcutaneous catheters and needles in place
IPC: A61B17/34
Filed: 2001-01-25
Abstract: Method of holding in place a transcutaneous implant by applying an adhesive in liquid form to the implant and the area of the patient's skin about the needle and allowing the adhesive to set. The implant is constituted by an infusion needle, a catheter or any transcutaneous implant. Whenever the adhesive is in liquid form, it has such a surface tension that it will flow along the implant and the skin to reach a terminal point, which is the point at which the implant is inserted. The adhesive is applied in liquid form and flows along the implant and the skin to reach the point at which the implant is inserted, and then allowed to set to hold the implant in place.
Patent IL-142671-A0 (IL)
Title: Method for producing 1-substituted 5-hydroxypyrazoles
IPC: C07B61/00
Filed: 1999-10-30
Abstract: A process for preparing compounds of the formula Iin which R1 is hydrogen, an aliphatic group having 1-8 carbon atoms, Cl-C6-alkoxycarbonyl, Cl-C6-alkylthiocarbonyl or a cyclic ring system having 3-14 ring atoms, and R2 is hydrogen, an aliphatic group having 1-8 carbon atoms, or R1 and R2 together with the carbon atom to which they are bound form a cyclic or bicyclic ring system having 3-14 ring atoms, comprises the preparation of compounds of the formula IIin which R3 and R4 are readily detachable groups and R1 and R2 are as defined above, as starting materials or intermediates and the cyclization of these under suitable reaction conditions to give compounds of the formula I. The intermediates of the formula II are novel.
Patent IL-144713-A0 (IL)
Title: Credit card system and method
IPC: G07F7/10
Filed: 2000-02-18
Abstract: A credit card system is provided which has the added feature of providing additional limited use credit card numbers and/or cards. These numbers and/or cards can be used for a single or limited use transaction, thereby reducing the potential for fraudulent reuse of these numbers and/or cards. The credit card system finds application to "card remote" transactions such as by phone or Internet. Additionally, when a single use or limited use credit card is used for "card present" transactions, so called "skimming" fraud is eliminated. Various other features enhance the credit card system which will allow secure trade without the use of elaborate encryption techniques. Methods for limiting, distributing and using a limited use card nubmer, controlling the validity of a limited use credit card number, conducting a limited used credit card number transaction and providing remote access devices for accessing a limited use credit card number are also provided.
Patent IL-165454-A0 (IL)
Title: Composition based on substituted 1,3-diphenylprop-2-en-en-1-one
IPC: A61P43/00
Filed: 2004-11-29
Abstract: The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives designed for therapeutic use. The inventive compositions are useful in particular for preventing or treating cardiovascular diseases, syndrome X, Ia restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms (benign or malignant tumors), neurodegenerative, dermatological diseases and disorders related to oxidative stress, for preventing or treating the effects of ageing in general and for example skin ageing, in particular in the field of cosmetics (occurrence of wrinkles and the like).
Patent IL-185156-A0 (IL)
Title: Systems and methods for managing information relating to medical fluids and containers therefor
IPC: G16H10/60
Filed: 2007-08-09
Abstract: The present invention relates to management of information relating to medical fluids, containers therefor, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tag) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.
Patent IL-185569-A0 (IL)
Title: Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
IPC: C12Q1/68
Filed: 2007-08-28
Abstract: The present invention relates to novel bicyclic and tricyclic nucleoside and nucleotide analogues as well as to oligonucleotides comprising such elements. The nucleotide analogues, LNAs ( L ocked Nucleoside  A nalogues), are able to provide valuable improvements to oligonucleotides with respect to affinity and specificity towards complementary RNA and DNA oligomers. The novel type of LNA modified oligonucleotides, as well as the LNAs as such, are useful in a wide range of diagnostic applications as well as therapeutic applications. Among these can be mentioned antisense applications, PCR applications, strand displacement oligomers, as substrates for nucleic acid polymerases, as nucleotide based drugs, etc. The present invention also relates to such applications.
Patent IL-189095-A0 (IL)
Title: Method and system for securely authorising the activation of a critical function on a drone
Filed: 2008-01-29
Abstract: The system has a ground control station (100) with an activation module (130) comprising a signing module for generating an activation message to activate critical functions (A-1B, A-1C, A-2B) for a designated effector module from a set of effector modules (230, 240, 330) of robotized platforms (200, 300). Each effector module has a verification unit for authenticating the message from the station. The verification unit verifies whether the received message is a signed integrated message for the effector module and authorizes the realization of the critical functions based on needs. An independent claim is also included for a method for authorizing activation of a critical function by a robotized platform.
Patent IL-193376-A0 (IL)
Title: Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
IPC: G01N33/569
Filed: 2008-08-11
Abstract: An isolated antibody specifically bindable to a human major histocompatibility complex (MHC) class I being complexed with a HLA-restricted tyrosinase antigen, wherein said antibody does not bind said human MHC class I in the absence of said HLA-restricted tyrosinase antigen, wherein said antibody does not bind said HLA-restricted tyrosinase antigen in the absence of said human MHC class I, and wherein said antibody binds tumor cells presenting said human MHC class I being complexed with said HLA-restricted tyrosinase antigen.
Patent IL-205506-A0 (IL)
Title: Spiroindolinone derivatives as anticancer agents
Filed: 2010-05-03
Abstract: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.
Patent AP-2001002181-A0 (AP)
Title: Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other toga viruses.
Inventor: AHLEM CLARENCE NATHANIEL
IPC: A61K31/5685
Filed: 1999-11-24
Abstract: The invention provides the use of 17-ketosteroid compounds, as well as derivatives, metabolites and precursors of such compounds, and pharmaceutically acceptable salts of any of these compounds, collectively defined herein as the "compounds of the present invention", in the treatment of prevention of hepatitis C type virus and/or hepatitis G type virus in patients in need of such treatment. in addition, the invention provides methods to treat or prevent togavirus infections, including infections by one or more alphaviruses, flaviviruses, such as yellow fever virus, hepatitis C virus and hepatitis G virus, rubella viruses, or pestiviruses, such as bovine virus diarrhea virus. In addition, the invention provides combination therapies including administration of one or more compound selected from plasma concentration-enhancing compounds, macrophage stimulating factor, oxidation agents, ribavirin and alpha interferon, and/or oxygen ventilation. The compounds of the present invention may also be used to ameliorate or reduce one or more symptoms associated with a togavirus infection.
Patent MA-38183-A1 (MA)
Title: Composés pyrrolopyrimidines en tant qu'inhibiteurs de kinase
Inventor: CHEN WEI
IPC: C07D487/04
Filed: 2013-11-14
Abstract: La présente invention concerne des composés qui forment des liaisons covalentes avec la tyrosine kinase de bruton (btk). L'invention concerne également des inhibiteurs irréversibles de btk. De plus, l'invention concerne également des inhibiteurs réversibles de btk. L'invention concerne également des compositions pharmaceutiques qui comprennent les composés. L'invention concerne des procédés d'utilisation des inhibiteurs de btk, seuls en combinaison avec d'autres agents thérapeutiques, pour le traitement de maladies auto-immunes ou d'états auto-immuns, de maladies hétéro-immunes ou d'états hétéro-immuns, le cancer, comprenant un lymphome, et des maladies ou états inflammatoires.
Patent MA-60452-A1 (MA)
Title: Procédé permettant d'éviter l’utilisation de produits chimiques dans le prétraitement d'installations de dessalement de l'eau de mer par osmose inverse
Inventor: MUÑOZ ELGUERA
IPC: C02F1/44
Filed: 2020-12-28
Abstract: La présente invention concerne un procédé permettant d'éviter l’utilisation de produits chimiques dans le prétraitement d'installations de dessalement de l'eau de mer par osmose inverse, par substitution des unités de traitement physique constitués de filtres à sable ayant une porosité de 20 µm (6), les filtres à porosité moyenne de 10 µm (10) et les filtres à porosité faible de 1 à 5 µm (13), ainsi que les systèmes de lavage des filtres à sable (7), des filtres à porosité moyenne (11) et des filtres à porosité faible (14), par une seule et unique unité de traitement physique, constituée d'un système à membranes d'ultrafiltration du type appelé mbr (23), ainsi que l’élimination du dosage d'anti-incrustants chimiques comme le na6p6o18(15) par le dosage de h2so4(25) pour réguler le ph de l'eau de mer entre 6 et 6,5 pour éviter la précipitation des sels dans les membranes à osmose inverse (18).
Patent UY-23931-A1 (UY)
Title: Conjunto de espejos accionados, de pelicula delgada, para ser utilizados en un sistema de proyeccion optica y metodo para la fabricacion del mismo.
Inventor: YONG-KI MIN
IPC: G02B26/02
Filed: 1995-03-09
Abstract: Se describe un conjunto de MxN espejos accionados de película delgada para ser utilizado en una disposición de proyección óptica, comprendiendo dicho conjunto una matriz activa, un conjunto de MxN miembros elásticos, un conjunto de MxN pares de estructuras de accionamiento, un conjunto de MxN espejos y un conjunto de MxN pares de miembros de soporte. Estando cada uno de los miembros elásticos provisto con un extremo distal y un extremo proximal, incluyendo el extremo proximal una primera y una segunda porciones de lengüeta, estando la primera y la segunda porciones de lengüeta separadas por una retracción definida entre ambas, incluyendo el extremo distal una saliente. Estando la saliente extendida desde cada uno de los miembros elásticos hacia el interior de la retracción de un miembro elástico sucesivo en el conjutno. Estando cada una de las estructuras accionadoras ubicado en las porciones de lengüeta primera y segunda en cada uno de los miembros elásticos, respectivamente, incluyendo cada una de las estructuras accionadoras un electrodo de bías, un electrodo de señal y una capa inductora de movimiento dispuesta entre los mismos. Estando cada uno de los espejos formado sobre la parte superior de los miembros elásticos. Siendo cada par de los miembros de soporte utilizado para sostener cada uno de los miembros elásticos en su lugar. Cuando el par de estructuras accionadoras se deforma en respuesta a una señal eléctrica, las porciones de lengüeta primera y segunda en el miembro elástico con las estructuras de accionamiento unidas a las mismas oscilan mientras que el resto del miembro elástico, y por lo tanto el espejo formado sobre la parte superior del mismo, permanece plano permitiendo de este modo que la totalidad del espejo refleje los rayos de luz. La figura 1 ilustra una vista en sección transversal de un conjunto de MxN espejos de película delgada accionados.
Patent UY-24292-A1 (UY)
Title: Caja fuerte con buzon perfeccionada
Inventor: JASPER NEWTON KEITH III
IPC: G07D11/00
Filed: 1996-07-24
Abstract: Una caja fuerte con un buzón para recibir y temporariamente almacenar dinero y otros valores desde una caja registradora o terminal de punto de venta. La caja fuerte con buzón utiliza aceptadores de billetes para transferir efectivo a cajitas selladas dentro de la caja fuerte. Un conjunto de montaje de caída de sobre permite transferir a la caja fuerte dinero o elementos no en efectivo no aceptador por el aceptador. La puerta de la caja fuerte tiene un montaje de control de puerta que incluye un resorte para contrabalancear el peso de la puerta para un movimiento controlado durante la apertura. La puerta se cierra con un par de pernos de puerta unidos a una leva de cierre, que se encuentra asegurada a un cerrojo dormid que evita el movimiento. Un control electrónico libera el cerrojo dormido en respuesta al ingreso de los números correctos, permitiendo que un cuadrante rotatorio del exterior de la caja fuerte mueva la leva de cierre y libere los pernos de la puerta. La caja fuerte comprende un procesador programado para controlar la operación de apertura y para mantener y producir varios informes de depósitos en la caja fuerte, permitiendo la sencilla correlación de esos depósitos con la operación de la caja fuerte durante el día de actividad comercial.
Patent UY-27275-A1 (UY)
Title: Composiciones y metodos para aumentar la biodisponibilidad de agentes farmacéuticos
Inventor: SHAM HING L
IPC: A61K31/7056
Filed: 2002-04-30
Abstract: Esta invención se relaciona con el aumento de la biodisponibilidad de agentes farmacéuticamente activos. En particular, se relaciona con el uso de lopinavir, sus equivalentes aceptables para uso farmacéutico y derivados del mismo como inhibidores de la glicoproteina P.
Patent UY-27496-A1 (UY)
Title: Bolsa
Inventor: MOCHAMMAD A MUNEN
IPC: B31B37/00
Filed: 2002-10-16
Abstract: Una bolsa, formada por lo menos en parte a partir de un laminado de papel y un material polimétrico, habiendo un extremo cerrado en fábrica y un extremo (que puede ser de boca abierta o estar configurado como válvula) utilizable por el cliente. Una de las formas de realización es la que consiste en un ensamble de una bolsa de este tipo, de boca abierta, a titulo de bolsa exterior protectora (preferentemente con fondo en bloque) alrededor de un saco interior provisto en fábrica, de una película de material polimérico o de un laminado.
Patent UY-29688-A1 (UY)
Title: Nueva forma cristalina v de la agomelatina, su procedimiento de preparación y las composiciones farmaceuticas que la contienen
Inventor: GERARD COQUEREL
IPC: A61K31/165
Filed: 2006-07-20
Abstract: La presente invención se refiere a una nueva forma cristalina V de agomelatina, a su procedimiento de preparación, así como a las composiciones farmacéuticas que la contienen como principio activo. La obtención de esta forma cristalina tiene por ventaja permitir la preparación de formulaciones farmacéuticas con una composición constante y reproducible, presentando características de disolución particularmente interesantes, lo cual resulta particularmente ventajoso cuando estas formulaciones están destinadas para la administración oral.
Patent UY-30940-A1 (UY)
Title: Chinela entera
Inventor: OLIVEIRA HUMBERTO LUCIANO DE
IPC: A43B3/00
Filed: 2008-02-27
Abstract: Se trata de dispositivo unitario y plano capaz de componer una chinela. Ese dispositivo plano presenta suela prolongada por dos alzas laterales opuestas. Una dispone de extremidad serillada y la otra según las aberturas. Para componer la chinela, basta elevar las dos alzas. Con relación a la suela, yuxtaponiento una a la otra y acoplándolas por la introducción de la extremidad recortada de curva en las aberturas de la otra.
Patent CH-705964-A1 (CH)
Title: System for implementing various applications for smart card, has programming device that checks application definitions and provides active entities, passive entities or mixed active and passive entities
Inventor: RIESEN THOMAS
IPC: G06F13/12
Filed: 2012-01-09
Abstract: The system (1) has a creation unit (2) that creates different forms of application definitions (3) and transfers over a distribution channel (4) to a programming devices (5). The programming device checks application definitions and provides active entities (6), passive entities (7) or mixed active and passive entities (8) in application definitions. The programming device is connected with a distribution server (9) using internet.